FDA approves biosimilar to Humira — IBD in the news

Edward V. Loftus Jr., M.D., discusses some of the issues surrounding this medication, and its potential benefits and drawbacks.

FDA approves of biosimilar to infliximab — IBD in the news

The FDA recently approved a biosimilar (CT-P13) to infliximab, which is used for treating people with IBD, as well as people with rheumatoid arthritis ankylosing spondylitis, psoriatic arthritis and plaque psoriasis.

Grand Rounds — Role of Circadian System in Regulation of Insulin Secretion: Implications for Diabetes Prevention and Treatment

Aleksey Matveyenko, Ph.D., presents Role of Circadian System in Regulation of Insulin Secretion: Implications for Diabetes Prevention and Treatment.

Grand Rounds — Evaluation of Diabetes Care Quality and Value: Role of Optum Labs in Patient-Centered Health Care Delivery Research

Rozalina G. McCoy, M.D., presents Evaluation of Diabetes Care Quality and Value: Role of Optum Labs in Patient-Centered Health Care Delivery Research.

Chromoendoscopy for inflammatory bowel disease

Michael F. Picco, M.D., Ph.D., and Michael B. Wallace, M.D., gastroenterologists at Mayo Clinic's campus in Jacksonville, Florida, demonstrate a simplified technique for application of indicarmine and other staining agents for surveillance ...

Non-celiac gluten sensitivity

Maria I. Vazquez Roque, M.D., discusses non-celiac gluten sensitivity (NCGS).